Drug intelligence / Profile preview

bletilla striata polysaccharide

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Bletilla striata polysaccharide (BSP) is a naturally derived, high-molecular-weight glucomannan extracted from the tubers of the orchid species *Bletilla striata*, which has a long history of use in traditional Chinese medicine. Chemically, BSP is a water-soluble heteropolysaccharide primarily composed of D-mannose and D-glucose residues linked by β-1,4-glycosidic bonds. It exhibits a wide range of pharmacological activities, including anti-inflammatory, antioxidant, immunomodulatory, hemostatic, and tissue-protective properties. In preclinical models, BSP has been shown to attenuate ischemia-reperfusion injury (IRI) following lung transplantation and protect against acute respiratory distress syndrome (ARDS) and metabolic dysfunction-associated steatotic liver disease (MASLD). Its therapeutic mechanism is largely mediated by the inhibition of the NLRP3/Caspase-1/GSDMD pyroptotic pathway, as well as the modulation of HMGB1/TLR4 signaling, which suppresses the release of pro-inflammatory cytokines such as IL-1β and IL-18.

Other names
BSPBletilla polysaccharidesBletilla striata glucomannanBletilla striata polysaccharides
02

Targets

NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)AMY (Pancreatic alpha-amylase)Sucrase-IsomaltaseCASP1 (Caspase-1)GSDMD (Gasdermin D)

Beyond the preview

Go deeper on bletilla striata polysaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bletilla striata polysaccharide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call